Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HTLV-1-mediated immunopathological CNS disease.

B Kitze1, K Usuku

  • 1Department of Neurology, Faculty of Medicine, University of Göttingen, Robert-Koch-Strasse 40, 37075 Göttingen, Germany.

Current Topics in Microbiology and Immunology
|May 17, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Matrix changes in articular cartilage in the knee of patients with rheumatoid arthritis after biological therapy: 1-year follow-up evaluation by T2 and T1ρ MRI quantification.

Clinical radiology·2018
Same author

MxA protein--an interferon beta biomarker in primary progressive multiple sclerosis patients.

European journal of neurology·2008
Same author

Interferon-beta1b treatment modulates cytokines in patients with primary progressive multiple sclerosis.

Acta neurologica Scandinavica·2006
Same author

Bronchoalveolar lymphocytosis correlates with human T lymphotropic virus type I (HTLV-I) proviral DNA load in HTLV-I carriers.

Thorax·2005
Same author

Interferon beta-1b modulates serum sVCAM-1 levels in primary progressive multiple sclerosis.

Acta neurologica Scandinavica·2004
Same author

Chronic progressive cervical myelopathy with HTLV-I infection: Variant form of HAM/TSP?

Neurology·2004

Human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a rare spinal cord disease. Immunogenetic factors and high proviral loads in infected T lymphocytes contribute to its development.

Area of Science:

  • Neurology
  • Immunology
  • Virology

Background:

  • Human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a chronic inflammatory disease affecting the spinal cord.
  • HAM/TSP is a rare condition, even among HTLV-1-infected individuals, suggesting a complex interplay of genetic and environmental factors.
  • The Human Leukocyte Antigen (HLA) complex plays a significant role, with specific genetic factors identified as either protective or predisposing to HAM/TSP development.

Purpose of the Study:

  • To investigate the immunogenetic factors and viral load characteristics associated with HAM/TSP.
  • To explore the role of HTLV-1 tax p40 protein in immune dysfunction observed in HAM/TSP patients.
  • To identify potential determinants for HAM/TSP pathogenesis, including T-lymphocyte behavior and viral gene expression.

Related Experiment Videos

Main Methods:

  • Analysis of immunogenetic factors within the HLA complex in HAM/TSP patients.
  • Quantification of HTLV-1 proviral loads in affected individuals.
  • Assessment of cellular and humoral immune responses in HAM/TSP patients.
  • Investigation of HTLV-1 tax p40 transactivation effects on cellular genes in infected CD4+ T lymphocytes.

Main Results:

  • HAM/TSP is characterized by high proviral loads and heightened cellular and humoral immune responses.
  • Specific immunogenetic factors within the HLA complex are associated with disease susceptibility or resistance.
  • HTLV-1 tax p40 may contribute to immune dysfunction by transactivating cellular genes in infected CD4+ T lymphocytes.

Conclusions:

  • The development of HAM/TSP is influenced by a combination of host immunogenetics and viral factors.
  • High proviral loads and specific immune responses are hallmarks of HAM/TSP.
  • Further research is needed to elucidate the precise mechanisms of HTLV-1 tax p40, T-lymphocyte expansion, and proviral gene regulation in HAM/TSP pathogenesis.